News about Industrial talks

BioMarin, n-Lorem Partner to Develop First Investigational Therapy for ReNU Syndrome

BioMarin, n-Lorem Partner to Develop First Investigational Therapy for ReNU Syndrome

BioMarin and the n-Lorem Foundation have partnered to develop an investigational antisense oligonucleotide therapy targeting the most common genetic variant associated with ReNU syndrome, a rare neurodevelopmental disorder with no approved treatments.

Industrial talks | 28/07/2026 | By News Bureau

IPC Signs Strategic MoUs to Advance Healthcare Innovation

IPC Signs Strategic MoUs to Advance Healthcare Innovation

The Indian Pharmacopoeia Commission (IPC) has signed Memoranda of Understanding (MoUs) with Council of Scientific and Industrial Research- Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) and Dr. Shakuntala Misra National Rehabilitation University (DSMNRU) to advance herbal medicine research and pharmacovigilance.

Industrial talks | 24/07/2026 | By News Bureau

Karnataka FDA and US FDA Strengthen Regulatory Partnership to Advance Food and Drug Safety

Karnataka FDA and US FDA Strengthen Regulatory Partnership to Advance Food and Drug Safety

Karnataka FDA and the US FDA have strengthened their regulatory partnership through a strategic collaboration focused on capacity building, joint training, regulatory innovation and global best practices to enhance food and pharmaceutical quality, manufacturing compliance, and public health standards.

Industrial talks | 23/07/2026 | By News Bureau 107

Sanofi Reshapes Executive Committee to Drive Next Phase of Growth

Sanofi Reshapes Executive Committee to Drive Next Phase of Growth

Sanofi has revamped its Executive Committee with a focused leadership team to drive strategic growth, accelerate innovation, and prepare for its next chapter.

Industrial talks | 23/07/2026 | By News Bureau 126

Fischer Medical Ventures Appoints Tay Chin Kwang as Finance Director

Fischer Medical Ventures Appoints Tay Chin Kwang as Finance Director

Fischer Medical Ventures has appointed Tay Chin Kwang as Group Director of Finance, Chairman Office, to strengthen leadership and drive global healthcare and life sciences growth.

Industrial talks | 22/07/2026 | By News Bureau

Dr. Jitendra Singh Launches India's First Engineering Biology Course

Dr. Jitendra Singh Launches India's First Engineering Biology Course

India launches its first Engineering Biology course as Dr. Jitendra Singh unveils a 2035 roadmap to advance Artificial Intelligence (AI)-driven biotechnology and bio-manufacturing.

Industrial talks | 17/07/2026 | By News Bureau

US FDA Approves Subcutaneous Sarclisa for Multiple Myeloma Across All Existing Indications

US FDA Approves Subcutaneous Sarclisa for Multiple Myeloma Across All Existing Indications

Sanofi’s SC formulation becomes the first oncology therapy approved for administration via both an on-body injector and manual subcutaneous injection, offering shorter treatment times for patients.

Industrial talks | 13/07/2026 | By News Bureau

Syngene International Appoints Siddharth Mittal as Managing Director and CEO

Syngene International Appoints Siddharth Mittal as Managing Director and CEO

Siddharth Mittal’s appointment as Managing Director and CEO to accelerate Syngene International’s global growth, strengthen execution and enhance its CRDMO leadership.

Industrial talks | 03/07/2026 | By News Bureau 112

Zydus Wellness appoints Dr. Shyam Ramakrishnan as Chief Scientific Officer

Zydus Wellness appoints Dr. Shyam Ramakrishnan as Chief Scientific Officer

Zydus Wellness has appointed Dr. Shyam Ramakrishnan as Chief Scientific Officer (CSO) to lead scientific strategy, drive innovation, and strengthen research in nutrition, health, and wellness.

Industrial talks | 03/07/2026 | By News Bureau 125

Galderma Receives US FDA Complete Response Letter for RelabotulinumtoxinA BLA, Reaffirms Commitment to US Launch

Galderma Receives US FDA Complete Response Letter for RelabotulinumtoxinA BLA, Reaffirms Commitment to US Launch

Galderma has received a Complete Response Letter from the US FDA for its RelabotulinumtoxinA Biologics License Application, with observations limited to manufacturing processes and analytical methods.

Industrial talks | 02/07/2026 | By News Bureau 182

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members